Status:
COMPLETED
COVID-19 Serology Screening and Strict Protocol in the Endoscopy Unit
Lead Sponsor:
Instituto Ecuatoriano de Enfermedades Digestivas
Conditions:
COVID
Eligibility:
All Genders
18-80 years
Brief Summary
The novel COronaVIrus Disease 19 (COVID-19) outbreak has impacted daily activities in nearly 210 countries and territories worldwide. In Ecuador, the city of Guayaquil has nearly two-thirds of the COV...
Detailed Description
Consecutive patients with appointment for endoscopic examination and procedures will be contacted via a telephone call by a pulmonologist, who will perform a triage with a screening questionnaire betw...
Eligibility Criteria
Inclusion
- Patients willing to participate
- Available serum samples for IgG and IgG antibodies against COVID-19
- Ability to complete the screening questionnaire
Exclusion
- Patients with respiratory symptoms
- Patients with COVID-19 active infection
Key Trial Info
Start Date :
April 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 15 2020
Estimated Enrollment :
111 Patients enrolled
Trial Details
Trial ID
NCT04374123
Start Date
April 20 2020
End Date
June 15 2020
Last Update
July 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ecuadorian Institute of Digestive Diseases
Guayaquil, Guayas, Ecuador, 090505